Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials

Autor: Jan Walewski, Michael Unterhalt, Christian H. Geisler, Michael Hallek, Martin Dreyling, J.K. Doorduijn, B. van der Holt, Vincent Ribrag, Anna Laurell, Johanna Kluin-Nelemans, Gilles Salles, Arne Kolstad, Wolfram Klapper, Mats Jerkeman, Michal Szymczyk, Christiane Pott, M. B. Van't Veer, R. Raty, Eva Hoster, Johannes Bloehdorn, Olivier Hermine

Publikováno v: Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2016, 30, pp.1428-1430. ⟨10.1038/leu.2015.322⟩
Leukemia, 30(6), 1428-1430. Nature Publishing Group

In patients with mantle cell lymphoma (MCL) up to 65 years, recommended first-line treatment consists of immuno-chemotherapy including high-dose cytarabine (HA), followed by autologous stem cell transplantation (ASCT) in complete (CR) or partial remi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4225c03e70c112a3637b53d16d49a26f
https://doi.org/10.1038/leu.2015.322

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma

Autor: Felix Reyes, Noel-Jean Milpied, H. Tilly, M. B. Van't Veer, Guillaume Cartron, Andrew Spencer, Andrew Grigg, Hanneke C. Kluin-Nelemans, Martin Dreyling, John F. Seymour, Max Wolf, Antonio Pezzutto, F. Morschhauser, John M. M. Raemaekers, Michael Pfreundschuh

Publikováno v: Annals of Oncology, 19, 2, pp. 247-53
Annals of Oncology, 19(2), 247-253. Elsevier Ltd.
Annals of Oncology, 19(2), 247-253. Oxford University Press
Annals of Oncology, 19, 247-53

Background: Protein kinase C beta (PKC beta), a pivotal enzyme in B-cell signaling and survival, is overexpressed in most cases of mantle cell lymphoma (MCL). Activation of PI3K/AKT pathway is involved in pathogenesis of MCL. Enzastaurin, an oral ser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dbc7338d2b5e4be7b275151a269cb39
https://research.rug.nl/en/publications/358dba26-44fb-4095-90fc-e8606af2657d

Lung cancer after treatment for Hodgkin's disease: focus on radiation effects

Autor: Lois B. Travis, Eric J. Holowaty, Marilyn Stovall, M. B. Van't Veer, Bengt Glimelius, F.E. van Leeuwen, Charles F. Lynch, Rochelle E. Curtis, Ethel S. Gilbert, Joseph F. Fraumeni, EA Clarke, John D. Boice, Mary Gospodarowicz, Timo Joensuu, Hans H. Storm, Martin Andersson, Eero Pukkala

Publikováno v: Radiation Research, 159, 161-173. Radiation Research Society

Aspects of radiation-induced lung cancer were evaluated in an international study of Hodgkin's disease. The study population consisted of 227 patients with lung cancer and 455 matched controls. Unique features included dose determinations to the spec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b92f9f7b46d617f066f9458d260e439
https://doi.org/10.1667/0033-7587(2003)159[0161:LCATFH]2.0.CO

Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†

Autor: M.J. Schalij, M. A. de Graaf, M. B. Van't Veer, A. de Roos, Arthur J. Scholte, Carien L. Creutzberg, Augustinus D.G. Krol, Laurien A. Daniëls, Hein Putter

Publikováno v: Annals of Oncology, 25(6), 1198-1203

Background Cardiovascular diseases are the most common nonmalignant cause of death in Hodgkin lymphoma (HL) survivors, especially after mediastinal irradiation. We investigated the role of computed tomographic coronary angiography (CTA) as a screenin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1600d5dc3dca4726d06eb54b2c2b3fc3
https://pubmed.ncbi.nlm.nih.gov/24692582

SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance

Autor: M. B. Van't Veer, Jan-Willem Gratama, J. J. M. Van Dongen, C. E. Van Der Schoot, H. J. Adriaansen, Johanna Kluin-Nelemans, E. R. Van Wering

Publikováno v: British Journal of Haematology. 112:337-343

For the diagnosis of leukaemia and leukaemic lymphoma, clinicians frequently have to rely on the results of immunophenotyping. To improve the quality of these results, the Dutch Foundation for Immunophenotyping of Haematological Malignancies (SIHON)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::01446e2d31b7c595847f599f15311866
https://doi.org/10.1046/j.1365-2141.2001.02500.x